JP2021518130A5 - - Google Patents

Info

Publication number
JP2021518130A5
JP2021518130A5 JP2020550615A JP2020550615A JP2021518130A5 JP 2021518130 A5 JP2021518130 A5 JP 2021518130A5 JP 2020550615 A JP2020550615 A JP 2020550615A JP 2020550615 A JP2020550615 A JP 2020550615A JP 2021518130 A5 JP2021518130 A5 JP 2021518130A5
Authority
JP
Japan
Prior art keywords
cells
population
acid sequence
nucleic acid
tcrab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020550615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021518130A (ja
JP7464528B2 (ja
Filing date
Publication date
Priority claimed from FR1852531A external-priority patent/FR3079239A1/fr
Application filed filed Critical
Publication of JP2021518130A publication Critical patent/JP2021518130A/ja
Publication of JP2021518130A5 publication Critical patent/JP2021518130A5/ja
Application granted granted Critical
Publication of JP7464528B2 publication Critical patent/JP7464528B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020550615A 2018-03-23 2019-03-22 多能性幹細胞からt細胞を入手するための新規な方法およびその使用 Active JP7464528B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1852531 2018-03-23
FR1852531A FR3079239A1 (fr) 2018-03-23 2018-03-23 Nouvelle methode d’obtention de cellules t a partir de cellules souches pluripotentes, et leurs utilisations
PCT/FR2019/050667 WO2019180394A1 (fr) 2018-03-23 2019-03-22 Nouvelle méthode d'obtention de cellules t à partir de cellules souches pluripotentes, et leurs utilisations

Publications (3)

Publication Number Publication Date
JP2021518130A JP2021518130A (ja) 2021-08-02
JP2021518130A5 true JP2021518130A5 (cg-RX-API-DMAC7.html) 2022-03-03
JP7464528B2 JP7464528B2 (ja) 2024-04-09

Family

ID=63557539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020550615A Active JP7464528B2 (ja) 2018-03-23 2019-03-22 多能性幹細胞からt細胞を入手するための新規な方法およびその使用

Country Status (5)

Country Link
US (1) US12054743B2 (cg-RX-API-DMAC7.html)
EP (1) EP3768828A1 (cg-RX-API-DMAC7.html)
JP (1) JP7464528B2 (cg-RX-API-DMAC7.html)
FR (1) FR3079239A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019180394A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3160113A1 (en) * 2019-11-08 2021-05-14 Sangamo Therapeutics, Inc. Generation of engineered regulatory t cells
BR112023014615A2 (pt) * 2021-01-20 2023-10-03 Seoul Nat Univ Hospital Células t reguladoras de receptor de antígeno quimérico anti-c4d e usos das mesmas.
GB202209676D0 (en) * 2022-06-30 2022-08-17 Gc Therapeutics Inc Methods and compositions for stem cell differentiation
JPWO2025033358A1 (cg-RX-API-DMAC7.html) * 2023-08-04 2025-02-13
CN118853569B (zh) * 2024-09-29 2025-03-04 星奕昂(上海)生物科技有限公司 一种拟胚体消化液及其在分离造血干细胞中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1784481A1 (en) 2004-08-25 2007-05-16 Technion Research And Development Foundation, Ltd. Methods of generating embryoid bodies using three dimensional scaffolds
US20110123502A1 (en) * 2007-02-21 2011-05-26 Barry Simon C Method for obtaining treg-cells
US8772028B2 (en) * 2008-11-07 2014-07-08 Sunnybrook Health Sciences Centre CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using
CA2753679C (en) * 2009-02-27 2021-03-02 Cellular Dynamics International, Inc. Differentiation of pluripotent cells
US20110027881A1 (en) * 2009-07-31 2011-02-03 St. Marianna University School Of Medicine Production method of immune cells
US8871510B2 (en) * 2009-12-03 2014-10-28 University Of Utah Research Foundation Methods for generating T lymphocytes from hematopoietic stem cells
EP3789487A1 (en) * 2013-04-03 2021-03-10 Memorial Sloan Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
WO2014180943A1 (en) 2013-05-08 2014-11-13 Vib Vzw Mcl-1 as critical regulator of foxp3+ regulatory t cell survival, and use thereof to treat severe immune disorders
FR3026744B1 (fr) * 2014-10-06 2024-04-19 Hopitaux Paris Assist Publique Methode de generation de progeniteurs de cellules t
US10626372B1 (en) * 2015-01-26 2020-04-21 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
CA3048996A1 (en) * 2015-12-08 2017-06-15 Regents Of The University Of Minnesota Human t cell derived from t cell-derived induced pluripotent stem cell and methods of making and using
US12076342B2 (en) * 2016-04-08 2024-09-03 The Governing Council Of The University Of Toronto Method for generating progenitor t cells from stem and/or progenitor cells and use of same

Similar Documents

Publication Publication Date Title
CN104487568B (zh) 人胚胎干细胞衍生的间充质样干细胞、方法及其应用
D’Alessio et al. Reparative T lymphocytes in organ injury
ES2599331T3 (es) Tratamiento de enfermedades y trastornos relacionados con el sistema inmunitario usando células adherentes derivadas del amnios
ES2765884T3 (es) Métodos de expansión y evaluación de linfocitos B y uso de linfocitos B expandidos para el tratamiento de enfermedades
JP6134032B2 (ja) 末梢免疫機能を調節するための方法及び組成物
US20140073050A1 (en) Method for activation treatment of antigen-presenting cell
JP6942466B2 (ja) 抗原特異的t細胞受容体遺伝子を有する多能性幹細胞の製造方法
JP5118624B2 (ja) 新規なヒトt細胞集団
WO2016010155A1 (ja) 抗原特異的t細胞受容体遺伝子を有する多能性幹細胞の製造方法
EP1708757A1 (en) Use of human cord blood-derived pluripotent cells for the treatment of disease
US12054743B2 (en) Method for obtaining T cells from pluripotent stem cells, and uses thereof
JP2013505296A5 (cg-RX-API-DMAC7.html)
WO2016010153A1 (ja) 免疫細胞療法用t細胞の誘導方法
WO2020158924A1 (ja) 母児間免疫寛容を誘導する方法
US12091684B2 (en) Platelet-derived mitochondria treatment and method of generating multipotent cells
JP2020533981A (ja) Cxcr5を過剰発現する間葉系幹細胞、その製造方法及び使用
US20230383255A1 (en) Genetically engineered dendritic cells to activate protein specific t cells for the treatment of viral and other pathogenic infections
US20130251675A1 (en) Methods for Modulating Inflammatory Responses
JP2025074700A (ja) 抗cd38-carを発現する細胞傷害性免疫担当細胞、その製造方法、および当該免疫担当細胞を含む医薬組成物